Department of Urology, Chinese PLA General Hospital, Beijing, China.
Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, China.
Eur Urol. 2020 Jul;78(1):77-86. doi: 10.1016/j.eururo.2019.04.019. Epub 2019 May 16.
Level III-IV robot-assisted inferior vena cava (IVC) thrombectomy (RA-IVCT) has been reported in limited series.
To report our initial series of level III-IV RA-IVCT with step-by-step procedures and 1-yr outcomes.
DESIGN, SETTING, AND PARTICIPANTS: From November 2014 to January 2018, 13 patients with level III-IV IVC tumor thrombi underwent RA-IVCT with a minimum of 1-yr follow-up.
Level III RA-IVCT requires liver mobilization and clamping of first porta hepatis (FPH), and suprahepatic and infradiaphragmatic IVC. Level IV RA-IVCT requires establishment of cardiopulmonary bypass (CPB). Thoracoscopy-assisted thrombectomy was performed for the intra-atrium part of the thrombus under CPB. Infradiaphragmatic RA-IVCT was completed in a manner similar to that of level III RA-IVCT.
Detailed techniques were described for various scenarios. Baseline and perioperative outcomes were reported, and descriptive statistical analysis was performed.
Median operative time was 465 (interquartile range [IQR]: 338-567) min. Median estimated intraoperative blood loss was 2000 (IQR: 1000-3000) ml. The rates of intraoperative blood transfusion and postoperative transformation to the intensive care unit ward were 92.3% and 100%, respectively. Median FPH blocking time was 40 (IQR: 25-60) min and the CPB time was 72 (IQR: 51-87) min. Three cases had grade IV complications, including two vascular injuries that were treated with intraoperative endoscopic sutures and one perioperative death. The perioperative mortality rate was 7.7%. During an 18-mo follow-up, two patients died and one patient progressed.
Although the risks involved are high, level III-IV RA-IVCT is feasible and serves as an alternative minimally invasive method for selected patients. It also requires more complex techniques and multidisciplinary cooperation.
We studied the treatment of patients with level III-IV inferior vena cava (IVC) tumor thrombi using a robotic approach. This technique was feasible for well-selected patients. However, level III-IV robot-assisted IVC thrombectomy requires more complex techniques and multidisciplinary cooperation.
有限的系列报道已经描述了三级和四级机器人辅助下下腔静脉(IVC)血栓切除术(RA-IVCT)。
报告我们采用逐步手术步骤和 1 年结果的三级和四级 RA-IVCT 的初始系列。
设计、地点和参与者:自 2014 年 11 月至 2018 年 1 月,13 例患有三级和四级 IVC 肿瘤血栓的患者接受了 RA-IVCT,随访时间至少为 1 年。
三级 RA-IVCT 需要肝的游离和第一肝门(FPH)的夹闭,以及肝上和膈下 IVC。四级 RA-IVCT 需要建立体外循环(CPB)。在 CPB 下进行胸腔镜辅助血栓切除术,以清除血栓的心房内部分。膈下 RA-IVCT 以类似于三级 RA-IVCT 的方式完成。
详细描述了各种情况下的技术。报告了基线和围手术期结果,并进行了描述性统计分析。
中位手术时间为 465(四分位距 [IQR]:338-567)min。中位估计术中出血量为 2000(IQR:1000-3000)ml。术中输血率和术后转至重症监护病房的比率分别为 92.3%和 100%。中位 FPH 阻断时间为 40(IQR:25-60)min,CPB 时间为 72(IQR:51-87)min。有 3 例发生四级并发症,包括 2 例血管损伤,经术中内镜缝合治疗,1 例围手术期死亡。围手术期死亡率为 7.7%。在 18 个月的随访期间,2 例患者死亡,1 例患者进展。
尽管风险较高,但三级和四级 RA-IVCT 是可行的,可为选定的患者提供一种替代的微创方法。它还需要更复杂的技术和多学科合作。
我们研究了使用机器人方法治疗三级和四级下腔静脉(IVC)肿瘤血栓的患者。对于选择合适的患者来说,这种技术是可行的。然而,三级和四级机器人辅助下 IVC 血栓切除术需要更复杂的技术和多学科合作。